Open AccessColorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis
Author(s) -
Alonso Vera,
Bridget K. Gunson,
Val Ussatoff,
Peter Nightingale,
Daniel Candinas,
Simon Radley,
A. D. Mayer,
J. A. C. Buckels,
P McMaster,
James Neuberger,
Darius Mirza
Publication year - 2003
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000058744.34965.38
Subject(s) - medicine , primary sclerosing cholangitis , gastroenterology , inflammatory bowel disease , colorectal cancer , ulcerative colitis , liver transplantation , colectomy , immunosuppression , dysplasia , transplantation , cancer , disease
Patients with primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD) may have an increased risk of developing colorectal cancer (CRC) after liver transplantation (LT). We evaluated our patients with PSC after LT to identify risk factors for CRC and its impact on survival.